Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 213 | 206 | 183 | 0 | 0 |
| Gross Profit | 213 | 206 | 183 | N/A | N/A |
| Operating Expenses | 22,742 | 148,378 | 11,663 | 8,492 | 6,159 |
| Operating Income | -22,529 | -148,172 | -11,480 | -8,492 | -6,159 |
| Interest Expense | 0 | 0 | 0 | 0 | 11 |
| Other Income | 1,101 | 214 | 498 | 6,037 | -27,897 |
| Pre-tax Income | -21,428 | -147,958 | -10,982 | -2,455 | -34,066 |
| Net Income Continuous | -21,428 | -147,958 | -10,982 | -2,455 | -34,066 |
| Net Income | $-21,428 | $-147,958 | $-10,982 | $-2,455 | $-34,066 |
| EPS Basic Total Ops | -4.70 | -77.50 | -11.60 | -3.60 | -93.00 |
| EPS Basic Continuous Ops | -4.70 | -77.50 | -11.62 | -3.56 | -93.03 |
| EPS Diluted Total Ops | -4.70 | -77.50 | -11.60 | -7.20 | -93.00 |
| EPS Diluted Continuous Ops | -4.70 | -77.50 | -11.62 | -3.31 | -93.03 |
| EPS Diluted Before Non-Recurring Items | -4.70 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-22,242 | $-148,172 | $-11,480 | $-8,492 | $-6,159 |